Canada Life Sciences Innovation Grants 2026
Access $720M+ in life sciences and biotechnology funding through 18+ federal and provincial programs. From biomanufacturing support to medical device pathways - accelerate your drug development, clinical trials, health technology, and pharmaceutical innovation initiatives.
Major Life Sciences & Biotechnology Programs
IRAP funding specifically for life sciences SMEs developing innovative biotechnology solutions, medical devices, diagnostics, therapeutics, and health technology applications.
Eligible Life Sciences Projects:
- • Drug discovery and development
- • Medical device prototypes
- • Diagnostic technology development
- • Biomanufacturing process innovation
Funding Support:
- • 60-80% of eligible R&D costs
- • Industrial Technology Advisor support
- • Access to research networks
- • Commercialization guidance
Support for clinical trials through CIHR, provincial health research programs, and specialized funding for drug trials, medical device testing, and health technology validation studies.
Clinical Trial Types:
- • Phase I safety studies
- • Phase II efficacy trials
- • Phase III confirmatory trials
- • Phase IV post-market surveillance
Funding Coverage:
- • Patient recruitment costs
- • Clinical site management
- • Data collection and analysis
- • Regulatory submission support
Specialized funding for medical device companies through design, prototyping, testing, regulatory approval (Health Canada), and commercialization stages.
Medical Device Categories:
- • Diagnostic imaging devices
- • Surgical instruments and implants
- • Monitoring and wearable devices
- • Therapeutic medical equipment
Regulatory Support:
- • Health Canada MDEL submission
- • FDA regulatory pathway guidance
- • CE marking for EU markets
- • Quality management system (ISO 13485)
Strategic support for biomanufacturing facilities, scale-up operations, GMP manufacturing, and pharmaceutical production capacity through federal and provincial programs.
Biomanufacturing Focus:
- • Biologics production facilities
- • Cell and gene therapy manufacturing
- • Vaccine production capacity
- • API (Active Pharmaceutical Ingredient)
Scale-Up Support:
- • GMP facility construction/upgrade
- • Manufacturing equipment acquisition
- • Process validation and optimization
- • Quality assurance systems
Life Sciences Funding by Sector
Provincial Life Sciences Programs
🍁 Leading Provincial Programs:
- Ontario Life Sciences: $280M for biotech and medical device innovation
- Quebec Biopharma Hub: $190M for drug development and manufacturing
- BC Life Sciences: $150M for health technology and diagnostics
- Alberta Health Innovation: $95M for medical device and digital health
🎯 Priority Life Sciences Areas:
- Precision Medicine: Personalized treatments and genomics
- Oncology: Cancer therapeutics and diagnostics
- Rare Diseases: Orphan drug development
- Digital Therapeutics: Software-based medical interventions
Life Sciences Funding Success Strategies
Ready to Access Life Sciences Funding?
Get our complete life sciences funding guide or work with specialists who have secured $95M+ in biotechnology grants across IRAP, clinical trials, and medical device programs.
Complete Application Guide
Get our step-by-step life sciences funding guide with clinical trials templates, medical device regulatory tools, and biomanufacturing strategies.
View Application GuideExpert Biotech Support
Work with life sciences funding specialists who have secured $95M+ with 76% success rate across biotech and medical device programs.
Get Expert Help76% success rate • $95M+ secured • IRAP, Clinical Trials & Medical Device expertise